ADAM metalloproteases and EGFR signalling

doi:10.1186/bcr637

Review

. 2003;5(5):223-4.

doi: 10.1186/bcr637. Epub 2003 Jul 21.

ADAM metalloproteases and EGFR signalling

Julia M W Gee¹, Janice M Knowlden

Affiliations

PMID: 12927027
PMCID: PMC314437
DOI: 10.1186/bcr637

Review

ADAM metalloproteases and EGFR signalling

Julia M W Gee et al. Breast Cancer Res. 2003.

. 2003;5(5):223-4.

doi: 10.1186/bcr637. Epub 2003 Jul 21.

Authors

Julia M W Gee¹, Janice M Knowlden

Affiliation

¹ Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Wales, UK. gee@cardiff.ac.uk

PMID: 12927027
PMCID: PMC314437
DOI: 10.1186/bcr637

No abstract available

PubMed Disclaimer

Cited by

Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW, Rougier JP, Park JW, Duh QY, Wong M, Werb Z, Clark OH. Yeh MW, et al. Endocr Relat Cancer. 2006 Dec;13(4):1173-83. doi: 10.1677/erc.1.01226. Endocr Relat Cancer. 2006. PMID: 17158762 Free PMC article.
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, Yang G, Li Y, Yao W, Vaddi K, Gazdar AF, Friedman SM, Jablons DM, Newton RC, Fridman JS, Minna JD, Scherle PA. Zhou BB, et al. Cancer Cell. 2006 Jul;10(1):39-50. doi: 10.1016/j.ccr.2006.05.024. Cancer Cell. 2006. PMID: 16843264 Free PMC article.
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.
Morgado-Pascual JL, Rayego-Mateos S, Valdivielso JM, Ortiz A, Egido J, Ruiz-Ortega M. Morgado-Pascual JL, et al. Biomed Res Int. 2015;2015:783538. doi: 10.1155/2015/783538. Epub 2015 May 6. Biomed Res Int. 2015. PMID: 26064952 Free PMC article.
A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.
Lukacova V, Zhang Y, Kroll DM, Raha S, Comez D, Balaz S. Lukacova V, et al. J Med Chem. 2005 Apr 7;48(7):2361-70. doi: 10.1021/jm0491703. J Med Chem. 2005. PMID: 15801829 Free PMC article.
Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
Lendeckel U, Kohl J, Arndt M, Carl-McGrath S, Donat H, Röcken C. Lendeckel U, et al. J Cancer Res Clin Oncol. 2005 Jan;131(1):41-8. doi: 10.1007/s00432-004-0619-y. Epub 2004 Sep 30. J Cancer Res Clin Oncol. 2005. PMID: 15565459

See all "Cited by" articles

References

1. Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003;22:1114–1124. doi: 10.1093/emboj/cdg111. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#borrell-pages. - DOI - PMC - PubMed
1. Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 2003;22:2411–2421. doi: 10.1093/emboj/cdg231. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#gschwind. - DOI - PMC - PubMed
1. Yan Y, Shirakabe K, Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 2002;158:21–26. doi: 10.1083/jcb.200112026. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#yan. - DOI - PMC - PubMed
1. Dong J, Opresko LK, Dempsey PJ, Lauffenburger DA, Coffey RJ, Wiley HS. Metalloprotease-mediated ligand release regulates autocrine signalling through the epidermal growth factor receptor. Proc Natl Acad Sci USA. 1999;96:6235–6240. doi: 10.1073/pnas.96.11.6235. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#dong. - DOI - PMC - PubMed
1. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signalling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002;80:231–238. doi: 10.1016/S0960-0760(01)00190-X. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#filardo. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

[1] Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003;22:1114–1124. doi: 10.1093/emboj/cdg111. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#borrell-pages. - DOI - PMC - PubMed

[2] Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 2003;22:1114–1124. doi: 10.1093/emboj/cdg111. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#borrell-pages. - DOI - PMC - PubMed

[3] Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 2003;22:2411–2421. doi: 10.1093/emboj/cdg231. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#gschwind. - DOI - PMC - PubMed

[4] Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 2003;22:2411–2421. doi: 10.1093/emboj/cdg231. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#gschwind. - DOI - PMC - PubMed

[5] Yan Y, Shirakabe K, Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 2002;158:21–26. doi: 10.1083/jcb.200112026. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#yan. - DOI - PMC - PubMed

[6] Yan Y, Shirakabe K, Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 2002;158:21–26. doi: 10.1083/jcb.200112026. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#yan. - DOI - PMC - PubMed

[7] Dong J, Opresko LK, Dempsey PJ, Lauffenburger DA, Coffey RJ, Wiley HS. Metalloprotease-mediated ligand release regulates autocrine signalling through the epidermal growth factor receptor. Proc Natl Acad Sci USA. 1999;96:6235–6240. doi: 10.1073/pnas.96.11.6235. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#dong. - DOI - PMC - PubMed

[8] Dong J, Opresko LK, Dempsey PJ, Lauffenburger DA, Coffey RJ, Wiley HS. Metalloprotease-mediated ligand release regulates autocrine signalling through the epidermal growth factor receptor. Proc Natl Acad Sci USA. 1999;96:6235–6240. doi: 10.1073/pnas.96.11.6235. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#dong. - DOI - PMC - PubMed

[9] Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signalling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002;80:231–238. doi: 10.1016/S0960-0760(01)00190-X. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#filardo. - DOI - PubMed

[10] Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signalling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002;80:231–238. doi: 10.1016/S0960-0760(01)00190-X. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr637.asp#filardo. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ADAM metalloproteases and EGFR signalling

Affiliation

ADAM metalloproteases and EGFR signalling

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials

Miscellaneous